We are reaching out to various quality measure stewards to ask their guidance on normalization of data used in quality measures.

For example, many medication value sets employ only NDC codes, but many of our customers' use RxNorm codes. We would like to have either NDC or RxNorm codes satisfy the measure numerator, as long as they are clinically equivalent, and in the case of medications that would extend beyond medication name and look down to equivalent dose, strength, route, etc. The same is true for value sets that include generic medications, we would like to "normalize" to include all brand name equivalents.

Another example is CVX codes, there are a few eCQM value sets for immunizations that include some CVX codes but not others. We would like to "normalize" these value sets to include additional CVX codes. Two examples are:

• Map CVX 17 Haemophilus influenzae type b vaccine, conjugate unspecified formulation TO Haemophilus Influenzae Type B (HiB) Vaccine value set
• Map CVX 45 hepatitis B vaccine, unspecified formulation TO Hepatitis B Vaccine value set

In general, if the codes are clinically equivalent, can we add them to the value set mappings?